查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球放射學人工智慧市場（至2030年）按交付類型（設備端、SaaS）、功能（分流、工作流程、臨床決策支援、影像擷取、影像處理、報告）、影像方式（CT、MRI、X光）、適應症（腫瘤、心血管、神經）、最終用戶（醫院、診斷影像中心）和地區分類
市場調查報告書
商品編碼
1942448

全球放射學人工智慧市場（至2030年）按交付類型（設備端、SaaS）、功能（分流、工作流程、臨床決策支援、影像擷取、影像處理、報告）、影像方式（CT、MRI、X光）、適應症（腫瘤、心血管、神經）、最終用戶（醫院、診斷影像中心）和地區分類

Radiology AI Market by Offering (On-Device, SaaS), Function (Triage, Workflow, CDSS, Acquisition, Processing, Reporting), Modality (CT, MRI, X-ray), Indication (Onco, Cardio, Neuro), End User (Hospital, Imaging Center), Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 347 Pages | 訂單完成後即時交付

價格

預計放射學人工智慧市場將從 2025 年的 7.6 億美元成長到 2030 年的 22.7 億美元，複合年成長率為 24.5%。

人工智慧驅動的診斷工具在早期癌症檢測、病灶分割和預測性治療計劃方面的應用日益廣泛，推動了這一成長，提高了診斷準確性，減輕了放射科醫生的工作量。

調查範圍
調查期 2024-2030
基準年 2024
預測期 2025-2030
單元 金額（美元）
部分 給藥形式、功能、方式、適應症、最終用戶
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

這些解決方案在腫瘤學、神經影像學和心血管影像學領域的應用不斷擴展，顯著增加了對能夠提供即時洞察、個人化診斷和工作流程最佳化的智慧 AI 平台的需求，從而在醫療技術領域創造了高價值的機會。

放射學人工智慧市場-IMG1

“預計在預測期內，工作流程最佳化領域將佔據顯著的市場佔有率。”

依功能分類，市場可細分為篩檢與分流、診斷影像與解讀（影像擷取、重建與增強、影像處理、分析與檢測、臨床決策支援等）、治療計畫與介入支援（劑量計畫與最佳化、手術計畫與引導、基於影像的分割與解剖建模等）、監測與追蹤、報告與文件、工作流程最佳化、研發以及其他流程。工作流程最佳化預計將實現最高的複合年成長率，這主要得益於其對影像科室的強大經濟和營運影響。在全球放射科醫生短缺和影像檢查量不斷成長的背景下，醫療機構正優先採用人工智慧技術，透過智慧工作清單協調和自動病例路由、即時設備利用以及更快的周轉時間來提高工作效率。這些解決方案簡化了技術人員和放射科醫師之間的溝通，減少了重拍的需要，促進了通訊協定標準化，並有助於消除人工管理任務。隨著醫院向以價值為基礎的醫療保健轉型，工作流程人工智慧將在預測期內成為一個關鍵的投資領域，因為它直接支援成本控制、加快病患處理速度和改善病患體驗。

“預計到2025年，軟體/SaaS領域將佔據最大的市場佔有率。”

按交付方式分類，軟體/SaaS解決方案預計將在2025年佔據最大的市場佔有率，這主要歸功於其易於部署、更新以及跨多種成像模式的可擴展性。這些平台可與現有的影像歸檔和通訊系統（PACS）、放射科資訊系統（RIS）和電子健康記錄（EHR）系統無縫整合，使放射科醫生能夠在日常工作流程中直接存取人工智慧分析結果，而無需進行重大的基礎設施改造。基於雲端的架構提高了可訪問性，支援模型的持續改進，並降低了初始資本支出。

此外，軟體供應商正利用訂閱和按使用量計費模式，在維持低進入門檻的同時，也能產生穩定的經常性收入。診斷人工智慧工具監管核准的不斷擴大，以及其在腫瘤學、神經病學和心臟病學等領域的強大應用案例，正進一步加速這項技術在市場上的主導地位。

“到2025年，北美將佔據很大佔有率”

預計到2025年，北美將佔據市場的主要佔有率，這主要得益於醫療基礎設施的大量投資、先進技術的應用以及對診斷成像服務的旺盛需求。尤其是在美國，聯邦政府對數位化醫療應用的獎勵以及人工智慧診斷工具的監管核准，促使人工智慧被廣泛整合到放射科的工作流程中。此外，癌症、心血管疾病和神經系統疾病等慢性病的日益增多，也推動了對先進診斷影像解決方案的需求，進而促進了人工智慧演算法在影像分析、分流和工作流程最佳化方面的應用。

此外，來自私營部門和公共部門的大力投資，以及人工智慧Start-Ups公司和成熟科技公司的高度集中，進一步鞏固了北美的市場領導地位。

然而，挑戰依然存在，例如HIPAA法規下的資料隱私問題，以及臨床醫生對全面採用人工智慧工具的猶豫不決。儘管存在這些障礙，但該地區憑藉先進的醫療基礎設施、有利的報銷政策、高額的研發投入以及對創新人工智慧技術的早期應用，繼續引領全球放射學人工智慧市場。

本報告調查了全球放射學人工智慧市場，並提供了市場概覽、影響市場成長的各種因素分析、技術和專利趨勢、法律制度、案例研究、市場規模趨勢和預測、按各個細分市場、地區/主要國家/地區進行的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章 引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 任務
  • 未滿足的需求和閒置頻段
  • 與相關市場和不同產業相關的跨領域機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 總體經濟指標
  • 供應鏈分析
  • 生態系分析
  • 定價分析
  • 2026-2027 年重要會議與活動
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措方案
  • 案例研究分析
  • 2025年美國關稅對輻射人工智慧市場的影響

第6章：技術進步、人工智慧影響、專利、創新與未來應用

  • 關鍵新興技術
    • 用於影像重建的生成式人工智慧
    • 多模態人工智慧整合
    • 聯邦學習框架
  • 互補技術
    • 基於雲端的成像平台
    • 區塊鏈用於資料完整性和可追溯性
    • 進階視覺化和AR/VR工具
  • 技術/產品藍圖
  • 專利分析
    • 放射學人工智慧市場專利揭露趨勢
    • 洞察：管轄範圍和領先申請人分析
  • 未來應用
    • 人工智慧驅動的精準放射診斷和個人化治療計劃
    • 自主成像與工作流程編配
    • 預測性與預防性診斷平台

第7章 監理環境

  • 地方法規和合規性

第8章：顧客狀況與購買行為

  • 決策流程
  • 買方相關利益者和採購評估標準
  • 招募障礙和內部挑戰
  • 來自各個終端使用者產業的未滿足需求
  • 市場盈利

第9章 輻射人工智慧市場：依供應形式分類

  • 裝置端軟體
  • 軟體/SaaS

第10章 放射線人工智慧市場按功能分類

  • 篩檢和分診
  • 診斷影像與解讀
  • 治療計劃和介入支持
  • 監測和後續行動
  • 報告和文檔
  • 工作流程最佳化
  • 研究與臨床開發
  • 其他功能

第11章 按模式分類的放射學人工智慧市場

  • CT
  • MRI
  • X光
  • 超音波
  • 乳房X光檢查
  • 其他

第12章 放射線人工智慧市場（依適應症分類）

  • 瘤
  • 心
  • 神經
  • 呼吸系統疾病
  • 整形外科
  • 女性健康
  • 其他

第13章 放射線人工智慧市場（依最終用戶分類）

  • 醫院
  • 診斷影像中心
  • 其他

第14章 放射線人工智慧市場（按地區分類）

  • 北美洲
    • 宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 南非
    • 其他

第15章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢
  • 收入分析
  • 市佔率分析
  • 品牌/軟體對比
  • 公司評估矩陣：主要企業
  • 公司估值矩陣：Start-Ups/中小企業
  • 估值和財務指標
  • 競爭場景
  • 主要企業
    • SIEMENS HEALTHINEERS AG
    • MICROSOFT
    • KONINKLIJKE PHILIPS NV
    • GE HEALTHCARE
    • FUJIFILM HOLDINGS CORPORATION
    • CANON MEDICAL SYSTEMS CORPORATION (CANON INC.)
    • MERATIVE
    • RADNET, INC. (DEEPHEALTH)
    • SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    • HOLOGIC, INC.
    • ENLITIC, INC.
  • 其他公司
    • AIDOC
    • VIZ.AI, INC.
    • NANOX
    • QURE.AI
    • ESAOTE SPA
    • BUTTERFLY NETWORK INC.
    • HEARTFLOW INC.
    • SUBTLE MEDICAL, INC.
    • HARISSON.AI
    • ECHONOUS INC.
    • QUIBIM
    • IMAGEN
    • EXO IMAGING, INC.
    • RAD AI

第16章調查方法

第17章附錄

Product Code: HIT 9593

The radiology AI market is projected to reach USD 2.27 billion by 2030 from USD 0.76 billion in 2025, at a CAGR of 24.5%. The growth is fueled by the increasing adoption of AI-driven diagnostic tools for early cancer detection, lesion segmentation, and predictive treatment planning, which enhance diagnostic accuracy and reduce radiologist workload.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsOffering, Function, Modality, Indication, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

The expanding application of these solutions in oncology, neuroimaging, and cardiovascular imaging is significantly boosting demand for intelligent AI platforms capable of delivering real-time insights, personalized diagnostics, and workflow optimization, creating a high-value opportunity in the healthcare technology landscape.

Radiology AI Market - IMG1

The workflow optimization segment is expected to witness significant market share during the forecast period.

Based on the function, the radiology AI market is segmented into screening & triage, diagnostic imaging & interpretation (image acquisition, reconstruction & enhancement, image processing, analysis & detection, clinical decision support, others), treatment planning & intervention support (dose planning & optimization, surgical planning & guidance, image-based segmentation & anatomical modeling, others), monitoring & follow-up, reporting & documentation, workflow optimization, research & clinical development, and others. Workflow optimization is projected to record the fastest CAGR in the radiology AI market, driven by its strong economic and operational impact across imaging departments. With global radiologist shortages and rising imaging volumes, health systems are prioritizing AI that enhances productivity through intelligent worklist orchestration and automated case routing, as well as real-time modality utilization and turnaround-time reduction. These solutions streamline communication between technologists and radiologists, reduce the need for repeat scans, facilitate protocol standardization, and help eliminate manual administrative tasks. As hospitals increasingly shift toward value-based care, workflow AI directly supports cost containment, faster patient throughput, and an improved patient experience, making it a key investment area over the forecast period.

The software/SaaS segment is expected to have the largest share in 2025 in the radiology AI market.

By offering, the software/SaaS solutions segment is expected to hold the largest market share in 2025, primarily because they are easier to deploy, update, and scale across multiple imaging modalities. These platforms seamlessly integrate with existing Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Electronic Health Record (EHR) systems, enabling radiologists to access AI insights directly within their routine workflows without requiring major infrastructure changes. Cloud-based architectures enhance accessibility, support continuous model improvement, and lower upfront capital expenditure.

Additionally, software vendors leverage subscription and usage-based pricing, making adoption budget-friendly while driving strong recurring revenue. Growing regulatory approvals for diagnostic AI tools, along with strong use cases in oncology, neurology, and cardiology, further accelerate the dominance of this technology in the market.

The North America region accounted for a substantial share of the radiology AI market in 2025.

The North American region accounted for a substantial share of the radiology AI market in 2025, driven by significant investments in healthcare infrastructure, the adoption of advanced technology, and high demand for imaging services. The US, in particular, has seen widespread integration of AI into radiology workflows, supported by federal incentives for digital health adoption and regulatory approvals for AI-powered diagnostic tools. In addition, the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has increased the demand for advanced imaging solutions, fueling the adoption of AI algorithms for image analysis, triage, and workflow optimization. For instance, in April 2025, according to the NIHCM Foundation, chronic diseases continue to pose a major burden on the US healthcare system, accounting for approximately 90% of the USD 4.5 trillion spent on healthcare in 2022, affecting around 60% of people in the US with multiple chronic conditions, thus driving high costs and complex care needs.

Robust investment from both private and public sectors, along with a high concentration of AI startups and established technology companies, further reinforced North American market leadership. Companies such as Aidoc (US), Enlitic, Inc. (US), and GE HealthCare (US) are actively developing AI-enabled platforms for CT, MRI, X-ray, and PET imaging, enhancing diagnostic accuracy and operational efficiency.

However, challenges such as data privacy concerns under HIPAA and clinician hesitancy to fully adopt AI tools remain. Despite these hurdles, the region continues to lead the global radiology AI market due to a combination of advanced healthcare infrastructure, favorable reimbursement policies, high R&D investment, and early adoption of innovative AI technologies.

These factors collectively reinforce North America's leadership in the radiology AI market.

The breakdown of primary participants is as mentioned below:

  • By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
  • By Designation - C Level: 40%, Director Level: 30%, and Others: 30%
  • By Region - North America: 40%, Europe: 30%, Asia Pacific: 25%, Latin America: 3%, Middle East & Africa: 2%

Key Players in the Radiology AI Market

The key players functioning in the radiology AI market include Siemens Healthineers AG (Germany), Microsoft (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Merative (US), DeepHealth (RadNet, Inc.) (US), Shanghai United Imaging Healthcare Co., LTD (China), Hologic, Inc. (US), and Enlitic, Inc. (US).

Research Coverage:

The report analyses the radiology AI market. It aims to estimate the market size and future growth potential of various market segments based on offering, function, modality, indication, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will help established firms and new entrants/smaller firms gauge the market's pulse, which, in turn, will help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights into:

  • Analysis of key drivers: Drivers (increasing medical imaging volumes, rising demand for AI solutions to alleviate radiologist workload, increase in regulatory clarity, accelerated approvals and government support, growing demand for AI-driven radiological image processing, growing funding for AI-focused startups, and rising collaborations with AI, tech, and analytics solution providers, Restraints (high implementation costs and ROI uncertainty, regulatory fragmentation across regions, and data quality and label scarcity for rarer indications), Opportunities (Growing demand for platform, multi-modal data, and OEM integration [PACS/EHR/marketplaces]), untapped growth potential in emerging healthcare markets, expansion of preventive care and population health management, and expansion of portable or handheld devices with AI integration), Challenges (integration challenges with legacy radiology systems, limited clinician trust and explainability demands, and concerns over data privacy and security) influencing the growth of the radiology AI market.
  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product launches in the radiology AI market
  • Market Development: Comprehensive information on the lucrative emerging markets, by offering, function, modality, indication, end user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the radiology AI market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the radiology AI market such as Siemens Healthineers AG (Germany), Microsoft (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Merative (US), DeepHealth (RadNet, Inc.) (US), Shanghai United Imaging Healthcare Co., LTD (China), Hologic, Inc. (US), and Enlitic, Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS & STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 RADIOLOGY AI MARKET OVERVIEW
  • 3.2 NORTH AMERICA: RADIOLOGY AI MARKET, BY OFFERING & COUNTRY
  • 3.3 RADIOLOGY AI MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing medical imaging volumes
      • 4.2.1.2 Rising demand for AI solutions to alleviate radiologist workload
      • 4.2.1.3 Increased regulatory clarity, accelerated approvals, and government support
      • 4.2.1.4 Growing demand for AI-driven radiological image processing
      • 4.2.1.5 Growing funding for AI-focused startups
      • 4.2.1.6 Rising collaborations with AI, tech, and analytics solution providers
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High implementation costs and ROI uncertainty
      • 4.2.2.2 Regulatory fragmentation across regions
      • 4.2.2.3 Data quality and label scarcity for rarer indications
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growing demand for platform, multi-modal data, and OEM integration (PACS/EHR/marketplaces)
      • 4.2.3.2 Untapped growth potential in emerging healthcare markets
      • 4.2.3.3 Expansion of preventive care and population health management
      • 4.2.3.4 Expansion of portable/handheld devices with AI integration
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Integration challenges with legacy radiology systems
      • 4.2.4.2 Limited clinician trust and explainability demands
      • 4.2.4.3 Concerns over data privacy and security
  • 4.3 UNMET NEEDS & WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 THREAT OF NEW ENTRANTS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY OFFERING (2024)
    • 5.5.2 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY REGION (2024)
  • 5.6 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.8 INVESTMENT & FUNDING SCENARIO
  • 5.9 CASE STUDY ANALYSIS
  • 5.10 IMPACT OF 2025 US TARIFFS ON RADIOLOGY AI MARKET
    • 5.10.1 INTRODUCTION
    • 5.10.2 KEY TARIFF RATES
    • 5.10.3 PRICE IMPACT ANALYSIS
    • 5.10.4 IMPACT ON COUNTRY/REGION
      • 5.10.4.1 US
      • 5.10.4.2 Europe
      • 5.10.4.3 Asia Pacific
    • 5.10.5 IMPACT ON END-USE INDUSTRIES
      • 5.10.5.1 Hospitals & healthcare systems
      • 5.10.5.2 Diagnostic imaging centers & independent radiology practices
      • 5.10.5.3 Academic, research, and life science institutions

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 GENERATIVE AI FOR IMAGE RECONSTRUCTION
    • 6.1.2 MULTIMODAL AI INTEGRATION
    • 6.1.3 FEDERATED LEARNING FRAMEWORKS
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 CLOUD-BASED IMAGING PLATFORMS
    • 6.2.2 BLOCKCHAIN FOR DATA INTEGRITY & TRACEABILITY
    • 6.2.3 ADVANCED VISUALIZATION & AR/VR TOOLS
  • 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4 PATENT ANALYSIS
    • 6.4.1 PATENT PUBLICATION TRENDS FOR RADIOLOGY AI MARKET
    • 6.4.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
  • 6.5 FUTURE APPLICATIONS
    • 6.5.1 AI-DRIVEN PRECISION RADIOLOGY & PERSONALIZED TREATMENT PLANNING
    • 6.5.2 AUTONOMOUS IMAGING & WORKFLOW ORCHESTRATION
    • 6.5.3 PREDICTIVE & PREVENTIVE DIAGNOSTIC PLATFORMS

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS & COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATORY FRAMEWORK
      • 7.1.2.1 North America
      • 7.1.2.2 Europe
      • 7.1.2.3 Asia Pacific
      • 7.1.2.4 Latin America
      • 7.1.2.5 Middle East & Africa
    • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
    • 8.4.1 UNMET NEEDS
    • 8.4.2 END-USER EXPECTATIONS
  • 8.5 MARKET PROFITABILITY

9 RADIOLOGY AI MARKET, BY OFFERING

  • 9.1 INTRODUCTION
  • 9.2 ON-DEVICE SOFTWARE
    • 9.2.1 RISING DEMAND FOR REAL-TIME, SECURE, AND LOW-LATENCY DIAGNOSTIC INTELLIGENCE TO ACCELERATE ADOPTION
  • 9.3 SOFTWARE/SAAS
    • 9.3.1 GROWING DEMAND FOR SCALABLE, COST-EFFICIENT, CLOUD-BASED RADIOLOGY AI TO SUPPORT MARKET GROWTH

10 RADIOLOGY AI MARKET, BY FUNCTION

  • 10.1 INTRODUCTION
  • 10.2 SCREENING & TRIAGE
    • 10.2.1 RISING NEED FOR RAPID IDENTIFICATION AND PRIORITIZATION OF CRITICAL FINDINGS TO DRIVE ADOPTION OF SCREENING & TRIAGE AI
  • 10.3 DIAGNOSTIC IMAGING & INTERPRETATION
    • 10.3.1 GROWING DEMAND FOR HIGHER DIAGNOSTIC ACCURACY AND WORKLOAD REDUCTION TO ACCELERATE ADOPTION
  • 10.4 TREATMENT PLANNING & INTERVENTION SUPPORT
    • 10.4.1 RISING DEMAND FOR PRECISE, PERSONALIZED TREATMENT PLANNING TO SUPPORT MARKET GROWTH
  • 10.5 MONITORING & FOLLOW-UP
    • 10.5.1 RISING NEED FOR QUANTITATIVE, LONG-TERM DISEASE MONITORING TO BOOST MARKET GROWTH
  • 10.6 REPORTING & DOCUMENTATION
    • 10.6.1 GROWING NEED FOR STANDARDIZED, AUTOMATED RADIOLOGY REPORTING TO CONTRIBUTE TO GROWTH
  • 10.7 WORKFLOW OPTIMIZATION
    • 10.7.1 RISING NEED FOR EFFICIENT, AUTOMATED RADIOLOGY WORKFLOWS TO FUEL GROWTH
  • 10.8 RESEARCH & CLINICAL DEVELOPMENT
    • 10.8.1 GROWING DEMAND FOR AI-ACCELERATED IMAGING RESEARCH TO PROPEL MARKET
  • 10.9 OTHER FUNCTIONS

11 RADIOLOGY AI MARKET, BY MODALITY

  • 11.1 INTRODUCTION
  • 11.2 CT
    • 11.2.1 GROWING NEED FOR FASTER, MORE ACCURATE CT DIAGNOSIS TO DRIVE MARKET GROWTH
  • 11.3 MRI
    • 11.3.1 ONGOING TECHNOLOGICAL ADVANCEMENTS IN MRI TECHNOLOGY TO SUPPORT GROWTH
  • 11.4 X-RAY
    • 11.4.1 GROWING NEED TO MANAGE RISING IMAGING VOLUMES TO DRIVE DEMAND FOR AI-ENHANCED X-RAY SYSTEMS
  • 11.5 ULTRASOUND
    • 11.5.1 ADVANTAGES SUCH AS MINIMALLY INVASIVE NATURE, LOW COST, AND ABSENCE OF IONIZING RADIATION TO BOOST ADOPTION
  • 11.6 MAMMOGRAPHY
    • 11.6.1 RISING BREAST CANCER BURDEN TO DRIVE AI ADOPTION IN MAMMOGRAPHY
  • 11.7 OTHER MODALITIES

12 RADIOLOGY AI MARKET, BY INDICATION

  • 12.1 INTRODUCTION
  • 12.2 ONCOLOGY
    • 12.2.1 RISING GLOBAL CANCER BURDEN TO ACCELERATE NEED FOR AI-DRIVEN DIAGNOSTICS
  • 12.3 CARDIOLOGY
    • 12.3.1 GROWING CARDIOVASCULAR DISEASE PREVALENCE TO BOOST ADOPTION OF CARDIAC IMAGING AI
  • 12.4 NEUROLOGY
    • 12.4.1 INCREASING STROKE AND NEURODEGENERATIVE CASES TO DRIVE RAPID AI INTEGRATION
  • 12.5 PULMONOLOGY/RESPIRATORY DISEASES
    • 12.5.1 EXPANDING LUNG DISEASE INCIDENCE TO FUEL DEMAND FOR AI-BASED DETECTION
  • 12.6 ORTHOPEDICS
    • 12.6.1 RISING TRAUMA AND OSTEOARTHRITIS CASES TO INCREASE NEED FOR MSK AI
  • 12.7 WOMEN'S HEALTH
    • 12.7.1 GROWING BREAST CANCER SCREENING VOLUMES TO ACCELERATE AI-ENABLED IMAGING ADOPTION
  • 12.8 OTHER INDICATIONS

13 RADIOLOGY AI MARKET, BY END USER

  • 13.1 INTRODUCTION
  • 13.2 HOSPITALS
    • 13.2.1 INCREASING DEPLOYMENT OF ADVANCED RADIOLOGY AI-ENABLED IMAGING SYSTEMS IN HOSPITALS TO DRIVE MARKET GROWTH
  • 13.3 DIAGNOSTIC IMAGING CENTERS
    • 13.3.1 RISING VOLUME OF IMAGING PROCEDURES TO STRENGTHEN NEED FOR AI-SUPPORTED IMAGE INTERPRETATION
  • 13.4 OTHER END USERS

14 RADIOLOGY AI MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 14.2.2 US
      • 14.2.2.1 US to dominate global radiology AI market
    • 14.2.3 CANADA
      • 14.2.3.1 Growing integration of AI in radiology supported by strong research & regulatory frameworks to drive market
  • 14.3 EUROPE
    • 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 14.3.2 GERMANY
      • 14.3.2.1 Growing need to advance diagnostic precision through AI-driven imaging to boost market
    • 14.3.3 FRANCE
      • 14.3.3.1 Need to address regulatory, ethical, and integration challenges in France's radiology AI market to boost growth
    • 14.3.4 UK
      • 14.3.4.1 Accelerating AI integration in diagnostic imaging across NHS to spur market growth
    • 14.3.5 ITALY
      • 14.3.5.1 Regulatory complexity and infrastructure gaps to constrain radiology AI expansion
    • 14.3.6 SPAIN
      • 14.3.6.1 Advancing digital imaging and AI integration across Spain's healthcare system to support growth
    • 14.3.7 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 14.4.2 JAPAN
      • 14.4.2.1 Strong digital health infrastructure and government-led innovation programs to support growth
    • 14.4.3 CHINA
      • 14.4.3.1 Rapid adoption and scale-up of AI-enabled radiology in China to drive growth
    • 14.4.4 INDIA
      • 14.4.4.1 Rising imaging volumes and need for scalable diagnostic solutions to fuel growth
    • 14.4.5 SOUTH KOREA
      • 14.4.5.1 Integration and validation challenges in South Korea's radiology AI market to slow growth
    • 14.4.6 AUSTRALIA
      • 14.4.6.1 Scaling clinical AI from pilot programs to nationwide deployment to boost market
    • 14.4.7 REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    • 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 14.5.2 BRAZIL
      • 14.5.2.1 Expanding clinical integration and local innovation in radiology AI to fuel market
    • 14.5.3 MEXICO
      • 14.5.3.1 Integration and regulatory barriers to hinder AI adoption in radiology
    • 14.5.4 REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST & AFRICA
    • 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 14.6.2 GCC COUNTRIES
      • 14.6.2.1 Saudi Arabia
        • 14.6.2.1.1 Advancing diagnostic intelligence through healthcare digitalization and AI integration to fuel growth
      • 14.6.2.2 UAE
        • 14.6.2.2.1 Accelerating smart healthcare transformation through AI-enabled radiology to spur growth
      • 14.6.2.3 Rest of GCC Countries
    • 14.6.3 SOUTH AFRICA
      • 14.6.3.1 Growing integration of AI to strengthen diagnostic imaging and clinical efficiency
    • 14.6.4 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET
  • 15.3 REVENUE ANALYSIS, 2020-2024
  • 15.4 MARKET SHARE ANALYSIS, 2024
  • 15.5 BRAND/SOFTWARE COMPARISON
  • 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 15.6.1 STARS
    • 15.6.2 EMERGING LEADERS
    • 15.6.3 PERVASIVE PLAYERS
    • 15.6.4 PARTICIPANTS
    • 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 15.6.5.1 Company footprint
      • 15.6.5.2 Region footprint
      • 15.6.5.3 Offering footprint
      • 15.6.5.4 Function footprint
      • 15.6.5.5 Modality footprint
      • 15.6.5.6 End-user footprint
  • 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 15.7.1 PROGRESSIVE COMPANIES
    • 15.7.2 RESPONSIVE COMPANIES
    • 15.7.3 DYNAMIC COMPANIES
    • 15.7.4 STARTING BLOCKS
    • 15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 15.7.5.1 Detailed list of key startups/SMEs
      • 15.7.5.2 Competitive benchmarking of startups/SMEs
  • 15.8 COMPANY VALUATION & FINANCIAL METRICS
    • 15.8.1 FINANCIAL METRICS
    • 15.8.2 COMPANY VALUATION
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
    • 15.9.2 DEALS
    • 15.9.3 OTHER DEVELOPMENTS
  • 15.10 KEY PLAYERS
    • 15.10.1 SIEMENS HEALTHINEERS AG
      • 15.10.1.1 Business overview
      • 15.10.1.2 Solutions offered
      • 15.10.1.3 Recent developments
        • 15.10.1.3.1 Product launches
        • 15.10.1.3.2 Deals
        • 15.10.1.3.3 Other developments
      • 15.10.1.4 MnM view
        • 15.10.1.4.1 Right to win
        • 15.10.1.4.2 Strategic choices
        • 15.10.1.4.3 Weaknesses & competitive threats
    • 15.10.2 MICROSOFT
      • 15.10.2.1 Business overview
      • 15.10.2.2 Solutions offered
      • 15.10.2.3 Recent developments
        • 15.10.2.3.1 Product launches
        • 15.10.2.3.2 Deals
        • 15.10.2.3.3 Other developments
      • 15.10.2.4 MnM view
        • 15.10.2.4.1 Right to win
        • 15.10.2.4.2 Strategic choices
        • 15.10.2.4.3 Weaknesses & competitive threats
    • 15.10.3 KONINKLIJKE PHILIPS N.V.
      • 15.10.3.1 Business overview
      • 15.10.3.2 Solutions offered
      • 15.10.3.3 Recent developments
        • 15.10.3.3.1 Product launches & approvals
        • 15.10.3.3.2 Deals
        • 15.10.3.3.3 Other developments
      • 15.10.3.4 MnM view
        • 15.10.3.4.1 Right to win
        • 15.10.3.4.2 Strategic choices
        • 15.10.3.4.3 Weaknesses & competitive threats
    • 15.10.4 GE HEALTHCARE
      • 15.10.4.1 Business overview
      • 15.10.4.2 Solutions offered
      • 15.10.4.3 Recent developments
        • 15.10.4.3.1 Product launches & approvals
        • 15.10.4.3.2 Deals
        • 15.10.4.3.3 Expansions
        • 15.10.4.3.4 Other developments
      • 15.10.4.4 MnM view
        • 15.10.4.4.1 Right to win
        • 15.10.4.4.2 Strategic choices
        • 15.10.4.4.3 Weaknesses & competitive threats
    • 15.10.5 FUJIFILM HOLDINGS CORPORATION
      • 15.10.5.1 Business overview
      • 15.10.5.2 Solutions offered
      • 15.10.5.3 Recent developments
        • 15.10.5.3.1 Product launches & approvals
        • 15.10.5.3.2 Deals
        • 15.10.5.3.3 Other developments
      • 15.10.5.4 MnM view
        • 15.10.5.4.1 Right to win
        • 15.10.5.4.2 Strategic choices
        • 15.10.5.4.3 Weaknesses & competitive threats
    • 15.10.6 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.)
      • 15.10.6.1 Business overview
      • 15.10.6.2 Solutions offered
      • 15.10.6.3 Recent developments
        • 15.10.6.3.1 Product launches & approvals
        • 15.10.6.3.2 Deals
        • 15.10.6.3.3 Other developments
    • 15.10.7 MERATIVE
      • 15.10.7.1 Business overview
      • 15.10.7.2 Solutions offered
      • 15.10.7.3 Recent developments
        • 15.10.7.3.1 Deals
        • 15.10.7.3.2 Expansions
        • 15.10.7.3.3 Other developments
    • 15.10.8 RADNET, INC. (DEEPHEALTH)
      • 15.10.8.1 Business overview
      • 15.10.8.2 Solutions offered
      • 15.10.8.3 Recent developments
        • 15.10.8.3.1 Product launches & approvals
        • 15.10.8.3.2 Deals
    • 15.10.9 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
      • 15.10.9.1 Business overview
      • 15.10.9.2 Solutions offered
      • 15.10.9.3 Recent developments
        • 15.10.9.3.1 Product launches & approvals
        • 15.10.9.3.2 Deals
        • 15.10.9.3.3 Other developments
    • 15.10.10 HOLOGIC, INC.
      • 15.10.10.1 Business overview
      • 15.10.10.2 Solutions offered
      • 15.10.10.3 Recent developments
        • 15.10.10.3.1 Product launches & approvals
        • 15.10.10.3.2 Deals
        • 15.10.10.3.3 Other developments
    • 15.10.11 ENLITIC, INC.
      • 15.10.11.1 Business overview
      • 15.10.11.2 Solutions offered
      • 15.10.11.3 Recent developments
        • 15.10.11.3.1 Product launches & approvals
        • 15.10.11.3.2 Deals
        • 15.10.11.3.3 Other developments
  • 15.11 OTHER PLAYERS
    • 15.11.1 AIDOC
    • 15.11.2 VIZ.AI, INC.
    • 15.11.3 NANOX
    • 15.11.4 QURE.AI
    • 15.11.5 ESAOTE S.P.A.
    • 15.11.6 BUTTERFLY NETWORK INC.
    • 15.11.7 HEARTFLOW INC.
    • 15.11.8 SUBTLE MEDICAL, INC.
    • 15.11.9 HARISSON.AI
    • 15.11.10 ECHONOUS INC.
    • 15.11.11 QUIBIM
    • 15.11.12 IMAGEN
    • 15.11.13 EXO IMAGING, INC.
    • 15.11.14 RAD AI

16 RESEARCH METHODOLOGY

  • 16.1 RESEARCH DATA
    • 16.1.1 SECONDARY DATA
      • 16.1.1.1 Key data from secondary sources
    • 16.1.2 PRIMARY DATA
      • 16.1.2.1 Key data from primary sources
      • 16.1.2.2 Breakdown of primary sources
  • 16.2 RESEARCH APPROACH
  • 16.3 MARKET SIZE ESTIMATION
  • 16.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 16.5 RESEARCH ASSUMPTIONS
    • 16.5.1 MARKET SIZING ASSUMPTIONS
    • 16.5.2 OVERALL STUDY ASSUMPTIONS
  • 16.6 RISK ASSESSMENT
  • 16.7 RESEARCH LIMITATIONS
    • 16.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 16.7.2 SCOPE-RELATED LIMITATIONS

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 RADIOLOGY AI MARKET: IMPACT ANALYSIS
  • TABLE 3 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011-2024
  • TABLE 4 RADIOLOGY AI MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 RADIOLOGY AI MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY OFFERING (2024)
  • TABLE 7 INDICATIVE PRICING FOR RADIOLOGY AI SOLUTIONS, BY REGION (2024)
  • TABLE 8 RADIOLOGY AI MARKET: KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 9 CASE STUDY 1: PRINCESS ALEXANDRA HOSPITAL NHS TRUST: ENHANCING DIAGNOSTIC CONFIDENCE WITH INTEGRATED AI
  • TABLE 10 CASE STUDY 2: EMBRACING AI FOR EFFICIENT CHEST X-RAY REPORTING AND QUALITY ASSURANCE
  • TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR RADIOLOGY AI MARKET
  • TABLE 13 RADIOLOGY AI MARKET: LIST OF PATENTS/PATENT APPLICATIONS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA
  • TABLE 20 REGULATORY SCENARIO OF EUROPE
  • TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC
  • TABLE 22 REGULATORY SCENARIO OF LATIN AMERICA
  • TABLE 23 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
  • TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 26 UNMET NEEDS IN RADIOLOGY AI MARKET
  • TABLE 27 END-USER EXPECTATIONS IN RADIOLOGY AI MARKET
  • TABLE 28 RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 29 RADIOLOGY AI MARKET FOR ON-DEVICE SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 RADIOLOGY AI MARKET FOR SOFTWARE/SAAS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 32 RADIOLOGY AI MARKET FOR SCREENING & TRIAGE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 33 RADIOLOGY AI MARKET FOR DIAGNOSTIC IMAGING & INTERPRETATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 34 RADIOLOGY AI MARKET FOR TREATMENT PLANNING & INTERVENTION SUPPORT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 RADIOLOGY AI MARKET FOR MONITORING & FOLLOW-UP, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 RADIOLOGY AI MARKET FOR REPORTING & DOCUMENTATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 RADIOLOGY AI MARKET FOR WORKFLOW OPTIMIZATION, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 RADIOLOGY AI MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 RADIOLOGY AI MARKET FOR OTHER FUNCTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 40 RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 41 RADIOLOGY AI MARKET FOR CT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 RADIOLOGY AI MARKET FOR MRI, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 43 RADIOLOGY AI MARKET FOR X-RAY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 RADIOLOGY AI MARKET FOR ULTRASOUND, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 RADIOLOGY AI MARKET FOR MAMMOGRAPHY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 RADIOLOGY AI MARKET FOR OTHER MODALITIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 48 RADIOLOGY AI MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 49 RADIOLOGY AI MARKET FOR CARDIOLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 50 RADIOLOGY AI MARKET FOR NEUROLOGY, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 RADIOLOGY AI MARKET FOR PULMONOLOGY/RESPIRATORY DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 RADIOLOGY AI MARKET FOR ORTHOPEDICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 RADIOLOGY AI MARKET FOR WOMEN'S HEALTH, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 RADIOLOGY AI MARKET FOR OTHER INDICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 55 RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 56 RADIOLOGY AI MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 RADIOLOGY AI MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 RADIOLOGY AI MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 RADIOLOGY AI MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: RADIOLOGY AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 66 US: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 67 US: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 68 US: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 69 US: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 70 US: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 71 CANADA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 72 CANADA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 73 CANADA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 74 CANADA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 75 CANADA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 76 EUROPE: RADIOLOGY AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 78 EUROPE: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 79 EUROPE: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 80 EUROPE: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 81 EUROPE: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 82 GERMANY: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 83 GERMANY: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 84 GERMANY: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 85 GERMANY: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 86 GERMANY: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 87 FRANCE: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 88 FRANCE: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 89 FRANCE: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 90 FRANCE: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 91 FRANCE: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 92 UK: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 93 UK: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 94 UK: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 95 UK: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 96 UK: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 97 ITALY: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 98 ITALY: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 99 ITALY: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 100 ITALY: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 101 ITALY: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 102 SPAIN: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 103 SPAIN: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 104 SPAIN: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 105 SPAIN: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 106 SPAIN: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 107 REST OF EUROPE: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 108 REST OF EUROPE: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 109 REST OF EUROPE: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 110 REST OF EUROPE: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 111 REST OF EUROPE: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: RADIOLOGY AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 118 JAPAN: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 119 JAPAN: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 120 JAPAN: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 121 JAPAN: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 122 JAPAN: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 123 CHINA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 124 CHINA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 125 CHINA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 126 CHINA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 127 CHINA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 128 INDIA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 129 INDIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 130 INDIA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 131 INDIA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 132 INDIA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 133 SOUTH KOREA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 134 SOUTH KOREA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 135 SOUTH KOREA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 136 SOUTH KOREA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 137 SOUTH KOREA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 138 AUSTRALIA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 139 AUSTRALIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 140 AUSTRALIA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 141 AUSTRALIA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 142 AUSTRALIA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 143 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 144 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 145 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 146 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 147 REST OF ASIA PACIFIC: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 148 LATIN AMERICA: RADIOLOGY AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 149 LATIN AMERICA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 150 LATIN AMERICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 151 LATIN AMERICA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 152 LATIN AMERICA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 153 LATIN AMERICA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 154 BRAZIL: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 155 BRAZIL: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 156 BRAZIL: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 157 BRAZIL: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 158 BRAZIL: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 159 MEXICO: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 160 MEXICO: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 161 MEXICO: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 162 MEXICO: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 163 MEXICO: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 164 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 165 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 166 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 167 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 168 REST OF LATIN AMERICA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 173 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 174 MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: RADIOLOGY AI MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 177 GCC COUNTRIES: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 178 GCC COUNTRIES: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 179 GCC COUNTRIES: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 180 GCC COUNTRIES: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 181 SAUDI ARABIA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 182 SAUDI ARABIA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 183 SAUDI ARABIA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 184 SAUDI ARABIA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 185 SAUDI ARABIA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 186 UAE: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 187 UAE: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 188 UAE: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 189 UAE: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 190 UAE: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 191 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 192 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 193 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 194 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 195 REST OF GCC COUNTRIES: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 196 SOUTH AFRICA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 197 SOUTH AFRICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 198 SOUTH AFRICA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 199 SOUTH AFRICA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 200 SOUTH AFRICA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 201 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY OFFERING, 2023-2030 (USD MILLION)
  • TABLE 202 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 203 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY MODALITY, 2023-2030 (USD MILLION)
  • TABLE 204 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 205 REST OF MIDDLE EAST & AFRICA: RADIOLOGY AI MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 206 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET, JANUARY 2022-NOVEMBER 2025
  • TABLE 207 RADIOLOGY AI MARKET: DEGREE OF COMPETITION
  • TABLE 208 RADIOLOGY AI MARKET: REGION FOOTPRINT
  • TABLE 209 RADIOLOGY AI MARKET: OFFERING FOOTPRINT
  • TABLE 210 RADIOLOGY AI MARKET: FUNCTION FOOTPRINT
  • TABLE 211 RADIOLOGY AI MARKET: MODALITY FOOTPRINT
  • TABLE 212 RADIOLOGY AI MARKET: END-USER FOOTPRINT
  • TABLE 213 RADIOLOGY AI MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 214 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS AND SMES, BY REGION
  • TABLE 215 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS AND SMES, BY MODALITY
  • TABLE 216 RADIOLOGY AI MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS AND SMES, BY END USER
  • TABLE 217 RADIOLOGY AI MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 218 RADIOLOGY AI MARKET: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 219 RADIOLOGY AI MARKET: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 220 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 221 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED
  • TABLE 222 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
  • TABLE 223 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 224 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 225 MICROSOFT: COMPANY OVERVIEW
  • TABLE 226 MICROSOFT: SOLUTIONS OFFERED
  • TABLE 227 MICROSOFT: PRODUCT LAUNCHES, JANUARY 2022-NOVEMBER 2025
  • TABLE 228 MICROSOFT: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 229 MICROSOFT: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 230 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 231 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
  • TABLE 232 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 233 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 234 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 235 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 236 GE HEALTHCARE: SOLUTIONS OFFERED
  • TABLE 237 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 238 GE HEALTHCARE: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 239 GE HEALTHCARE: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
  • TABLE 240 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 241 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 242 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
  • TABLE 243 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 244 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 245 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 246 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): COMPANY OVERVIEW
  • TABLE 247 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): SOLUTIONS OFFERED
  • TABLE 248 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 249 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 250 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 251 MERATIVE: COMPANY OVERVIEW
  • TABLE 252 MERATIVE: SOLUTIONS OFFERED
  • TABLE 253 MERATIVE: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 254 MERATIVE: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
  • TABLE 255 MERATIVE: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 256 RADNET, INC. (DEEPHEALTH): COMPANY OVERVIEW
  • TABLE 257 RADNET, INC. (DEEPHEALTH): SOLUTIONS OFFERED
  • TABLE 258 RADNET, INC. (DEEPHEALTH): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 259 RADNET, INC. (DEEPHEALTH): DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 260 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW
  • TABLE 261 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: SOLUTIONS OFFERED
  • TABLE 262 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 263 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 264 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 265 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 266 HOLOGIC, INC.: SOLUTIONS OFFERED
  • TABLE 267 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 268 HOLOGIC, INC. : DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 269 HOLOGIC, INC.: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 270 ENLITIC, INC.: COMPANY OVERVIEW
  • TABLE 271 ENLITIC, INC.: SOLUTIONS OFFERED
  • TABLE 272 ENLITIC, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 273 ENLITIC, INC.: DEALS, JANUARY 2022-NOVEMBER 2025
  • TABLE 274 ENLITIC, INC.: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
  • TABLE 275 AIDOC: COMPANY OVERVIEW
  • TABLE 276 VIZ.AI, INC.: COMPANY OVERVIEW
  • TABLE 277 NANOX: COMPANY OVERVIEW
  • TABLE 278 QURE.AI: COMPANY OVERVIEW
  • TABLE 279 ESAOTE S.P.A.: COMPANY OVERVIEW
  • TABLE 280 BUTTERFLY NETWORK INC.: COMPANY OVERVIEW
  • TABLE 281 HEARTFLOW, INC.: COMPANY OVERVIEW
  • TABLE 282 SUBTLE MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 283 HARISSON.AI: COMPANY OVERVIEW
  • TABLE 284 ECHONOUS INC.: COMPANY OVERVIEW
  • TABLE 285 QUIBIM: COMPANY OVERVIEW
  • TABLE 286 IMAGEN: COMPANY OVERVIEW
  • TABLE 287 EXO IMAGING, INC.: COMPANY OVERVIEW
  • TABLE 288 RAD AI: COMPANY OVERVIEW
  • TABLE 289 FACTOR ANALYSIS
  • TABLE 290 RISK ASSESSMENT: RADIOLOGY AI MARKET

List of Figures

  • FIGURE 1 RADIOLOGY AI MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL RADIOLOGY AI MARKET, 2023-2030
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOLOGY AI MARKET, 2020-2025
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF RADIOLOGY AI MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN RADIOLOGY AI MARKET, 2025-2030
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIOLOGY AI MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 8 RISING IMAGING VOLUMES TO DRIVE GROWTH IN RADIOLOGY AI MARKET
  • FIGURE 9 SOFTWARE/SAAS SEGMENT IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
  • FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 11 RADIOLOGY AI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 FDA-APPROVED AI-ENABLED RADIOLOGY (2019-MAY 2025)
  • FIGURE 13 PROVEN ACCURACY RATES OF AI IN DIAGNOSTIC IMAGING
  • FIGURE 14 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009-2024
  • FIGURE 15 US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2009-2024
  • FIGURE 16 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009-2023
  • FIGURE 17 RADIOLOGY AI MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 18 RADIOLOGY AI MARKET: SUPPLY CHAIN ANALYSIS (2024)
  • FIGURE 19 RADIOLOGY AI MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 22 PATENT PUBLICATION TRENDS IN RADIOLOGY AI MARKET, 2015-2025
  • FIGURE 23 JURISDICTION & TOP APPLICANT ANALYSIS FOR RADIOLOGY AI MARKET
  • FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR RADIOLOGY AI MARKET (JANUARY 2015 TO NOVEMBER 2025)
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 27 NORTH AMERICA: RADIOLOGY AI MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: RADIOLOGY AI MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN RADIOLOGY AI MARKET, 2020-2024 (USD MILLION)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RADIOLOGY AI MARKET (2024)
  • FIGURE 31 RADIOLOGY AI MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 32 RADIOLOGY AI MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 33 RADIOLOGY AI MARKET: COMPANY FOOTPRINT
  • FIGURE 34 RADIOLOGY AI MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 35 EV/EBITDA OF KEY VENDORS
  • FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 37 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
  • FIGURE 38 MICROSOFT: COMPANY SNAPSHOT
  • FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 40 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 41 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 42 CANON MEDICAL SYSTEMS CORPORATION (CANON INC.): COMPANY SNAPSHOT
  • FIGURE 43 RADNET, INC. (DEEPHEALTH): COMPANY SNAPSHOT
  • FIGURE 44 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 45 HOLOGIC, INC.: COMPANY SNAPSHOT
  • FIGURE 46 ENLITIC, INC.: COMPANY SNAPSHOT
  • FIGURE 47 RESEARCH DESIGN
  • FIGURE 48 PRIMARY SOURCES
  • FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 52 SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 53 RADIOLOGY AI MARKET: REVENUE ESTIMATION APPROACH
  • FIGURE 54 BOTTOM-UP APPROACH: END-USER SPENDING ON RADIOLOGY AI
  • FIGURE 55 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025-2030)
  • FIGURE 56 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 57 TOP-DOWN APPROACH
  • FIGURE 58 DATA TRIANGULATION METHODOLOGY